Literature DB >> 11096579

Amebiasis.

.   

Abstract

More than 80% of cases of amebic liver abscess can be managed with a 14-day course of intravenous or oral metronidazole. In cases of suspected amebic liver abscess, treatment should be started before diagnostic confirmation. If no clinical improvement is evident by 72 to 96 hours, treatment should be changed to dehydroemetine and chloroquine. Invasive treatment is necessary only in patients in whom medical treatment fails within 5 days or in whom signs of clinically severe disease are present. A 10-day course with a luminal agent such as paromomycin to eliminate intestinal cysts, which are resistant to imidazoles, should always follow treatment of the liver abscess. Percutaneous catheter drainage is indicated in patients with impending rupture, with a lesion 6 cm or more in diameter, with an abscess located in the left lobe or high in the dome of the right lobe, or in whom medical treatment fails. Although sympathetic pleural effusion is not an indication for drainage, direct pulmonary involvement or spread to pleural or lung tissues requires drainage. Intraperitoneal rupture and peritonitis necessitate open surgical drainage. Only a small minority of amebic liver abscesses are secondarily infected by other organisms. Because relapses are possible, feces should be checked for cysts monthly for several months after therapy.

Entities:  

Year:  1999        PMID: 11096579     DOI: 10.1007/s11938-999-0036-z

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  15 in total

1.  EPIDEMIOLOGY OF AMEBIASIS IN THE US.

Authors:  M M BROOKE
Journal:  JAMA       Date:  1964-05-11       Impact factor: 56.272

2.  A comparative evaluation of percutaneous catheter drainage for resistant amebic liver abscesses.

Authors:  J P Singh; A Kashyap
Journal:  Am J Surg       Date:  1989-07       Impact factor: 2.565

3.  Perforated amebic liver abscess: clinical analysis of 110 cases.

Authors:  X Y Meng; J X Wu
Journal:  South Med J       Date:  1994-10       Impact factor: 0.954

Review 4.  Protozoa. Amebiasis.

Authors:  E Li; S L Stanley
Journal:  Gastroenterol Clin North Am       Date:  1996-09       Impact factor: 3.806

5.  Percutaneous treatment of liver abscesses: needle aspiration versus catheter drainage.

Authors:  C L Rajak; S Gupta; S Jain; Y Chawla; M Gulati; S Suri
Journal:  AJR Am J Roentgenol       Date:  1998-04       Impact factor: 3.959

6.  Prognostic markers in amebic liver abscess: a prospective study.

Authors:  M P Sharma; S Dasarathy; N Verma; S Saksena; D K Shukla
Journal:  Am J Gastroenterol       Date:  1996-12       Impact factor: 10.864

7.  Amebic liver abscess: a therapeutic approach.

Authors:  J E Thompson; S Forlenza; R Verma
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

8.  Outcome of hepatic amebic abscesses managed with three different therapeutic strategies.

Authors:  C Filice; G Di Perri; M Strosselli; E Brunetti; S Dughetti; D H Van Thiel; C Scotti-Foglieni
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

9.  Amebiasis. The ancient scourge is still with us.

Authors:  N Holtan
Journal:  Postgrad Med       Date:  1988-06       Impact factor: 3.840

10.  Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen.

Authors:  T Zhang; P R Cieslak; S L Stanley
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

View more
  1 in total

1.  Chloroquine has a cytotoxic effect on Acanthamoeba encystation through modulation of autophagy.

Authors:  Bijay Kumar Jha; Hui-Jung Jung; Incheol Seo; Hyun Ah Kim; Seong-Il Suh; Min-Ho Suh; Won-Ki Baek
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.